India, April 21 -- Indian shares look set to open on a cautious note on Tuesday as investors react to a sell-off in U.S. equities overnight amid concerns that President Trump's policies will boost inf... Read More
India, April 21 -- Nomura agreed to acquire Macquarie's U.S. and European public asset management business, with approximately US$180 billion in retail and institutional client assets across equities,... Read More
India, April 21 -- It was a weak performance by the U.S. Dollar during the week ended April 18, amidst renewed concerns about economic growth in the U.S. President Donald Trump's renewed call to cut i... Read More
India, April 21 -- Sentiment remained volatile and cautious as markets speculated on the threats to independence of the Federal Reserve. Concerns about trade war jeopardizing global economic growth as... Read More
India, April 21 -- Shares of Upexi, Inc. (UPXI) soared over 530% on Monday morning after the company announced a private placement of $100 million to fund the accumulation of cryptocurrency Solano. U... Read More
India, April 21 -- Toyota Motor's unit Hino Motors and Mitsubishi Fuso Truck and Bus, a Daimler Truck subsidiary, are nearing the finalization of a merger agreement, according to Nikkei Asia. The two... Read More
India, April 21 -- Thoma Bravo is in advanced discussions to acquire Boeing Co.'s (BA) Jeppesen navigation unit, Blomberg reported citing people familiar with the matter. A deal, potentially exceedin... Read More
India, April 21 -- Aerovate Therapeutics, Inc. (AVTE), a clinical-stage biopharmaceutical company, on Monday announced that its stockholders have approved the proposed merger with Jade Biosciences, In... Read More
India, April 21 -- TMD Energy Ltd. announced Monday the pricing of its initial public offering of 3.1 million ordinary shares at a price to public of US$3.25 per Share for the total gross proceeds of ... Read More
India, April 21 -- Gilead Sciences, Inc. (GILD) Monday reported positive topline results from the Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating Trodelvy in combination with Merck's Keytruda in patien... Read More